These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34755412)

  • 21.
    Ragab N; Bauer J; Botermann DS; Uhmann A; Hahn H
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alveolar rhabdomyosarcoma: a prognostically unfavorable rhabdomyosarcoma type and its necessary distinction from embryonal rhabdomyosarcoma.
    Harms D
    Curr Top Pathol; 1995; 89():273-96. PubMed ID: 7882714
    [No Abstract]   [Full Text] [Related]  

  • 23. A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.
    Owosho AA; Huang SC; Chen S; Kashikar S; Estilo CL; Wolden SL; Wexler LH; Huryn JM; Antonescu CR
    Oral Oncol; 2016 Oct; 61():89-97. PubMed ID: 27688110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma.
    Wong KY; Yao Q; Yuan LQ; Li Z; Ma ESK; Chim CS
    Sci Rep; 2018 Sep; 8(1):13522. PubMed ID: 30201956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
    van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
    Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
    Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O
    J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma.
    Ganti R; Skapek SX; Zhang J; Fuller CE; Wu J; Billups CA; Breitfeld PP; Dalton JD; Meyer WH; Khoury JD
    Mod Pathol; 2006 Sep; 19(9):1213-20. PubMed ID: 16729016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MYOD1 as a prognostic indicator in rhabdomyosarcoma.
    Ahmed AA; Habeebu S; Farooqi MS; Gamis AS; Gonzalez E; Flatt T; Sherman A; Surrey L; Arnold MA; Conces M; Koo S; Dioufa N; Barr FG; Tsokos MG
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29085. PubMed ID: 33913590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel t(2;20)(q35;p12) in embryonal rhabdomyosarcoma.
    Ho RH; Johnson J; Dev VG; Whitlock JA
    Cancer Genet Cytogenet; 2004 May; 151(1):73-7. PubMed ID: 15120913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining an embryonal rhabdomyosarcoma endotype.
    Ricker CA; Crawford K; Matlock K; Lathara M; Seguin B; Rudzinski ER; Berlow NE; Keller C
    Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological characteristics and treatment outcomes of Chinese patients with genitourinary embryonal rhabdomyosarcoma.
    Zhan XK; Zhang S; Cao BW; Wang JW; Li JL; Sun YK; Zhang W; Yang L; Zhou AP; Chi YH; Li YX; Ma JH; Li CL
    World J Surg Oncol; 2015 May; 13():190. PubMed ID: 26018798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
    Shern JF; Selfe J; Izquierdo E; Patidar R; Chou HC; Song YK; Yohe ME; Sindiri S; Wei J; Wen X; Rudzinski ER; Barkauskas DA; Lo T; Hall D; Linardic CM; Hughes D; Jamal S; Jenney M; Chisholm J; Brown R; Jones K; Hicks B; Angelini P; George S; Chesler L; Hubank M; Kelsey A; Gatz SA; Skapek SX; Hawkins DS; Shipley JM; Khan J
    J Clin Oncol; 2021 Sep; 39(26):2859-2871. PubMed ID: 34166060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spindle cell rhabdomyosarcoma of the neck with t(6;8) translocation: report of a case and literature review.
    Mentrikoski MJ; Golden W; Bourne TD; Legallo R
    Pediatr Dev Pathol; 2013; 16(1):35-8. PubMed ID: 23113671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathological study of 145 childhood rhabdomyosarcoma cases].
    He LJ; Wang L; Sun N; Huang CR; Zhu XD; Lang ZQ
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):225-8. PubMed ID: 15256113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.
    Kouraklis G; Triche TJ; Wesley R; Tsokos M
    Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.
    Odeniyide P; Yohe ME; Pollard K; Vaseva AV; Calizo A; Zhang L; Rodriguez FJ; Gross JM; Allen AN; Wan X; Somwar R; Schreck KC; Kessler L; Wang J; Pratilas CA
    Oncogene; 2022 May; 41(21):2973-2983. PubMed ID: 35459782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.
    Butel T; Karanian M; Pierron G; Orbach D; Ranchere D; Cozic N; Galmiche L; Coulomb A; Corradini N; Lacour B; Proust S; Guerin F; Boutroux H; Rome A; Mansuy L; Vérité C; Defachelles AS; Tirode F; Minard-Colin V
    Cancer Med; 2020 Apr; 9(8):2698-2709. PubMed ID: 32087612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.
    Kaczirek K; Ciuleanu TE; Vrbanec D; Marton E; Messinger D; Liegl-Atzwanger B; Wrba F; Knittelfelder R; Lindner E; Zielinski CC; Streubel B; Brodowicz T
    Clin Colorectal Cancer; 2015 Jun; 14(2):91-8. PubMed ID: 25666295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas.
    Knobbe CB; Reifenberger J; Reifenberger G
    Acta Neuropathol; 2004 Dec; 108(6):467-70. PubMed ID: 15517309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies.
    Chen Y; Takita J; Hiwatari M; Igarashi T; Hanada R; Kikuchi A; Hongo T; Taki T; Ogasawara M; Shimada A; Hayashi Y
    Genes Chromosomes Cancer; 2006 Jun; 45(6):583-91. PubMed ID: 16518851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.